Bath & Body Works, Inc. (BMV:BBWI)
| Market Cap | 60.53B -52.5% |
| Revenue (ttm) | 126.44B -0.2% |
| Net Income | 11.25B -18.7% |
| EPS | 53.93 -13.9% |
| Shares Out | n/a |
| PE Ratio | 5.38 |
| Forward PE | 6.54 |
| Dividend | 14.71 (5.06%) |
| Ex-Dividend Date | Feb 20, 2026 |
| Volume | n/a |
| Average Volume | 1,540 |
| Open | 291.00 |
| Previous Close | 291.00 |
| Day's Range | 291.00 - 291.00 |
| 52-Week Range | 267.00 - 656.25 |
| Beta | n/a |
| RSI | 35.83 |
| Earnings Date | May 27, 2026 |
About Bath & Body Works
Bath & Body Works, Inc. operates as a specialty retailer of personal care and home fragrance products. The company offers body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, hand soaps, body lotions, and body creams, as well as sanitizer and other products. It sells its products under the Bath & Body Works and other brand names through retail stores and e-commerce sites in the United States and Canada, as well as through international stores operated by partners under the... [Read more]
Financial Performance
In fiscal year 2026, Bath & Body Works's revenue was $7.29 billion, a decrease of -0.22% compared to the previous year's $7.31 billion. Earnings were $649.00 million, a decrease of -18.67%.
Financial numbers in USD Financial StatementsNews
Bath & Body Works price target lowered to $19 from $22 at UBS
UBS lowered the firm’s price target on Bath & Body Works to $19 from $22 and keeps a Neutral rating on the shares. The firm sees a balanced upside/downside skew…
Bath & Body Works price target lowered to $20 from $26 at TD Cowen
TD Cowen analyst Jonna Kim lowered the firm’s price target on Bath & Body Works to $20 from $26 and keeps a Buy rating on the shares. The firm updated…
Bath & Body Works Declares Cash Dividend
COLUMBUS, Ohio, May 15, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) announced today the declaration of its regular quarterly dividend of $0.20 per share payable on June 19, 2026, to ...
Bath & Body Works assumed with a Neutral at Piper Sandler
Piper Sandler assumed coverage of Bath & Body Works with a Neutral rating and $20 price target The firm acknowledges the stock is inexpensive trading at about seven times 2026…
Bath & Body Works To Report First Quarter Results On May 27, 2026
COLUMBUS, Ohio, May 13, 2026 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) announced today that it plans to report its first quarter 2026 financial results before market open on Wednesday, ...
LandBridge Q1 Earnings Call Highlights
LandBridge NYSE: LB reported higher first-quarter revenue and adjusted EBITDA and raised its full-year 2026 outlook, citing improved visibility into commercial activity, stronger basin conditions and ...
LandBridge Announces First Quarter 2026 Results
HOUSTON--(BUSINESS WIRE)--LandBridge Company LLC (NYSE: LB; NYSE TX: LB) (the “Company,” or “LandBridge”) today announced its financial and operating results for the first quarter ended March 31, 2026...
Bath & Body Works appoints Gabai-Pinsky as chief brand & product officer
Bath & Body Works announced the appointment of Veronique Gabai-Pinsky as its first-ever chief brand& product officer, effectiveMay 18, building on her contributions as a creative product & brand advis...
Bath & Body Works Appoints Veronique Gabai-Pinsky as Chief Brand & Product Officer
As chief brand & product officer, Gabai-Pinsky will lead brand, product, creative and design to further accelerate Bath & Body Works' transformation and innovation As chief brand & product officer, Ga...
Bath & Body Works Proxy statement: Proxy filing
Bath & Body Works filed a proxy statement on April 28, 2026, providing details for shareholder voting and corporate governance matters.
Bath & Body Works Proxy statement: Proxy filing
Bath & Body Works filed a proxy statement on April 28, 2026, providing details for shareholder voting and corporate governance matters.
Bath & Body Works says it can't compete without Amazon
Bath & Body Works is turning to Amazon as part of its turnaround effort, CEO Daniel Heaf said. The e-commerce giant is helping the mall staple reach new customers.
LandBridge Schedules First Quarter Earnings Release and Conference Call
HOUSTON--(BUSINESS WIRE)--LandBridge Company LLC (NYSE: LB; NYSE TX: LB) ("LandBridge") today announced that it will release its financial results for the first quarter of 2026 after market close on W...
LandBridge Announces Agreement with PowerBridge for the Development of a 2 GW Powered Data Center Campus
HOUSTON--(BUSINESS WIRE)--LandBridge Company LLC (NYSE: LB) (“LandBridge”) today announced that it has entered into a lease development agreement with PowerBridge LLC (“PowerBridge”) providing the opt...
Bath & Body Works announces Mother’s Day collaboration with Vera Bradley
Bath & Body Works (BBWI) is partnering with Vera Bradley (VRA) on a limited-edition Mother’s Day collaboration that brings together fragrance, design and gifting across body care, home fragrance and…
LandBridge Announces Webcast of Upcoming Investor Day
HOUSTON--(BUSINESS WIRE)--LandBridge Company LLC (NYSE: LB) (the “Company,” or “LandBridge”) will conduct a live video webcast of its Investor Day on March 19, 2026 at 1:00 pm ET. The webcast will be ...
Bath & Body Works Stock (BBWI) Slips as Analysts Remain Cautious Despite Strong Earnings
Bath & Body Works stock dipped after analysts weighed in following the company’s latest earnings report.
Bath & Body Works price target raised to $25 from $23 at Telsey Advisory
Telsey Advisory raised the firm’s price target on Bath & Body Works to $25 from $23 and keeps a Market Perform rating on the shares. The firm is encouraged by…
Bath & Body Works price target raised to $23 from $22 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Bath & Body Works to $23 from $22 and keeps a Hold rating on the shares.
Bath & Body Works price target raised to $26 from $17 at Goldman Sachs
Goldman Sachs raised the firm’s price target on Bath & Body Works to $26 from $17 and keeps a Neutral rating on the shares. The company’s new business strategy announced…
Bath & Body Works price target lowered to $22 from $23 at JPMorgan
JPMorgan lowered the firm’s price target on Bath & Body Works to $22 from $23 and keeps a Neutral rating on the shares. The updated the company’s model post the…
Bath & Body Works price target raised to $25 from $21 at Barclays
Barclays raised the firm’s price target on Bath & Body Works to $25 from $21 and keeps an Equal Weight rating on the shares. The firm updated the company’s model…
Wells Fargo recommends buying pullback on Bath & Body Works
Wells Fargo maintained an Overweight rating and $29 price target on Bath & Body Works following the company’s post-Q4 earnings pullback. The firm added that the turnaround story is “right…
Bath & Body Works price target raised to $30 from $26 at BofA
BofA analyst Lorraine Hutchinson raised the firm’s price target on Bath & Body Works to $30 from $26 and keeps a Buy rating on the shares. The firm, which thinks…
Bath & Body Works Earnings Call Transcript: Q4 2026
Q4 net sales and EPS exceeded expectations despite a 2% sales decline, driven by early progress on innovation and digital expansion. 2026 will be an investment year, with sales expected to decline but international and digital channels poised for growth.